Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Am J Ophthalmol. 2010 Oct;150(4):534–542.e2. doi: 10.1016/j.ajo.2010.04.031

TABLE 3.

Incidence of Structural Ocular Complications and of Visual Acuity Loss in HLA-B27-Associated Uveitis

Event n/Na Rate/EY (95% CI)b
Any ocular complication 21/53 0.224 (0.146–0.344)
 Elevated intraocular pressure (> 21 mm Hg) 25/102 0.102 (0.069–0.151)
 Posterior Subcapsular Cataracts (≥ trace opacity) 20/99 0.091 (0.059–0.143)
 Posterior Synechaie 12/89 0.053 (0.030–0.094)
 Epiretinal Membrane 7/109 0.022 (0.011–0.047)
 Cystoid Macular Edema 5/109 0.016 (0.007–0.039)
 Band Keratopathy 3/109 0.010 (0.003–0.030)
 Hypotony (< 6 mm Hg) 2/110 0.006 (0.001–0.025)
Vision Loss 20/50 or worse 15/92 0.062 (0.037–0.102)
Vision Loss 20/200 or worse 7/100 0.023 (0.011–0.049)
a

Number of events/Number of eyes at risk

b

Incidence rate is number of events in an affected eye per eye-years at risk